Physician profile
Lori Bowers
NPI 1235146010
$22,196.33
in general payments reported to CMS, 2019-2025
12 companies · $59.40 in 2025
The $59.40 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $5,010 · 2021: $1,197 · 2022: $4,363 · 2023: $1,184 · 2024: $63.08 · 2025: $59.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,184 · Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,184.00 |
| Food and Beverage | $122.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20,567.95 | 2019-2023 | |
| Astrazeneca Ab | $1,390.26 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.92 | 2020-2021 | |
| Hologic Sales and Service, LLC | $24.85 | 2025 | Thinprep 2000 Processor, Aptima |
| Abbott Laboratories | $24.07 | 2024 | Freestyle Libre 3 |
| Genentech USA, INC. | $22.80 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $21.06 | 2025 | Ajovy |
| Glaxosmithkline, LLC. | $19.53 | 2024 | Bexsero |
| Cranial Technologies, INC | $19.48 | 2024 | Doc Band |
| Phadia US INC. | $16.48 | 2019 | |
| Shire North American Group INC | $16.44 | 2019 | |
| Qiagen, LLC | $13.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Bowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.